[Attempt at evaluating the HL-A system relationship with Rh-D antigen-stimulalated immunological response]. 1977

B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak

In 96 subjects immunized artificially with antigen D HLA system antigens were determined. In 21 cases antibodies were not produced, in 70 good response to antigen D was observed, in 5 cases antibodies were produced with considerable delay. The method of two-step lymphocytotoxicity test of Terasaki was used. The reference panel included 90 sera with antibodies to antigens: 1, 2, 3, 11, W23, W24, W25, W26, W28, W29, W30, W31 from first sublocus, and 7, 8, 12, 13, W5, W10, W14, W15, W16, W17, W18, W21, W22, W27 from second sublocus. Seventy of the immunized volunteers responded by production of antibodies (group I). and 21 failed to respond (group II). The frequency of different HLA antigens was analysed statistically in both groups using the chi square test and comparing the results with the frequency in a random population of healthy non-immunized subjects. Statistically significant differences were found in antigens 2, 3 and W24 from sublocus HLA-A (LA) and W16 from sublocus HLA-B (Four). In the non-responding group antigens HL-A3 and W24 were more frequent than in the group producing anti-D antibodies. In the latter group antigen HL-A2 prevailed. It seems that the gene determining rapid recognition of antigen D is connected with presence of HL-A2 antigen.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008233 Lymphotoxin-alpha A tumor necrosis factor family member that is released by activated LYMPHOCYTES. Soluble lymphotoxin is specific for TUMOR NECROSIS FACTOR RECEPTOR TYPE I; TUMOR NECROSIS FACTOR RECEPTOR TYPE II; and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14. Lymphotoxin-alpha can form a membrane-bound heterodimer with LYMPHOTOXIN-BETA that has specificity for the LYMPHOTOXIN BETA RECEPTOR. TNF Superfamily, Member 1,TNF-beta,Tumor Necrosis Factor Ligand Superfamily Member 1,Tumor Necrosis Factor-beta,Lymphotoxin,Lymphotoxin-alpha3,Soluble Lymphotoxin-alpha,alpha-Lymphotoxin,Lymphotoxin alpha,Lymphotoxin alpha3,Lymphotoxin-alpha, Soluble,Soluble Lymphotoxin alpha,Tumor Necrosis Factor beta,alpha Lymphotoxin
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
January 1976, Acta haematologica Polonica,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
August 1970, British journal of haematology,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
October 1974, Gut,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
January 1965, Acta paediatrica Academiae Scientiarum Hungaricae,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
May 1967, The Journal of clinical investigation,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
March 1977, Tissue antigens,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
January 1975, Acta haematologica Polonica,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
January 1965, Vox sanguinis,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
January 1986, Vox sanguinis,
B Maczyńska-Rusiniak, and I Chojnacka-Jachimiak
January 1973, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!